PAK6 increase chemoresistance and is a prognostic marker for stage II and III colon cancer patients undergoing 5-FU based chemotherapy

p21-Activated kinase 6 (PAK6) has been implicated in radiotherapy and docetaxel resistance. We have further evaluated PAK6 as a predictor of 5-fluorouracil (5-FU) treatment response in colon cancer. Here we report that in colon cancer PAK6 promotes tumor progression and chemoresistance both in vitro...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jian, Lu, Huijun, Yan, Dongwang, Cui, Feifei, Wang, Xiaoliang, Yu, Fudong, Xue, Yingming, Feng, Xiaodong, Wang, Jingtao, Wang, Xiao, Jiang, Tao, Zhang, Meng, Zhao, Senlin, Yu, Yang, Tang, Huamei, Peng, Zhihai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381600/
https://www.ncbi.nlm.nih.gov/pubmed/25426562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381600/
https://www.ncbi.nlm.nih.gov/pubmed/25426562

Ejemplares similares